{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lenexa",
      "state": "KS",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "65734",
      "recalling_firm": "Remel Inc",
      "address_1": "12076 Santa Fe Trail Dr",
      "address_2": "N/A",
      "postal_code": "66215-3519",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide Distribution including AL, CA, CO, FL, IA,  KS, LA, MA, MS, NE, NH, NJ, NY, OK, OR, RI, TN, TX, VA, WA WI, and Puerto Rico.",
      "recall_number": "Z-0528-2014",
      "product_description": "Oxoid Antimicrobial Susceptibility Test Discs, CTO425B Ciprofloxacin CIP 5 mcg, 50 discs per cartridge, 5 cartridges per box.  The firm name on the box label is Oxoid Ltd., Basingstoke, UK.    Used in the semi-quantitative agar diffusion test method for in vitro susceptibility testing to assist in the determination of a suitable antibiotic agent for treatment purposes.",
      "product_quantity": "60/5/50-disc cartridge boxes",
      "reason_for_recall": "Boxes labeled as CIP5 may contain cartridges of AMP5.",
      "recall_initiation_date": "20121121",
      "center_classification_date": "20131217",
      "termination_date": "20140312",
      "report_date": "20131225",
      "code_info": "Lot number: 1220205, exp July 21, 2015"
    }
  ]
}